Analyst Ratings For Dova Pharmacuet (NASDAQ:DOVA)
Today, J P Morgan Chase & Co initiated coverage on Dova Pharmacuet (NASDAQ:DOVA) with a Overweight with a price target of $35.00.
There are 1 hold rating, 2 buy ratings on the stock.
The current consensus rating on Dova Pharmacuet (NASDAQ:DOVA) is Buy (Score: 2.67) with a consensus target price of $29.67 per share, a potential 33.21% upside.
Some recent analyst ratings include
- 7/24/2017-J P Morgan Chase & Co initiated coverage with a Overweight rating.
- 7/24/2017-Leerink Swann initiated coverage with a Market Perform rating.
- 7/24/2017-Jefferies Group LLC initiated coverage with a Buy rating.
Recent Trading Activity for Dova Pharmacuet (NASDAQ:DOVA)
Shares of Dova Pharmacuet closed the previous trading session at 22.27 down -0.48 -2.11% with 138,727 shares trading hands.